IRIS
JANNINI, EMMANUELE ANGELO FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 50.323
AS - Asia 9.715
EU - Europa 6.204
SA - Sud America 1.122
AF - Africa 152
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 7
Totale 67.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 49.912
SG - Singapore 4.629
IT - Italia 1.876
CN - Cina 1.256
HK - Hong Kong 1.028
BR - Brasile 931
RU - Federazione Russa 821
JP - Giappone 664
VN - Vietnam 547
DE - Germania 538
UA - Ucraina 519
IE - Irlanda 513
FR - Francia 465
GB - Regno Unito 399
KR - Corea 347
BD - Bangladesh 284
CA - Canada 246
FI - Finlandia 245
PL - Polonia 217
ID - Indonesia 171
TW - Taiwan 170
IN - India 166
NL - Olanda 153
SE - Svezia 141
ES - Italia 90
MX - Messico 75
TH - Thailandia 58
PH - Filippine 55
AR - Argentina 54
AU - Australia 52
MY - Malesia 47
ZA - Sudafrica 47
IR - Iran 43
TR - Turchia 43
IQ - Iraq 39
EC - Ecuador 34
BE - Belgio 29
CO - Colombia 29
RO - Romania 29
EG - Egitto 28
AT - Austria 27
GR - Grecia 24
NO - Norvegia 23
CL - Cile 22
UZ - Uzbekistan 21
JM - Giamaica 19
SA - Arabia Saudita 19
VE - Venezuela 19
AE - Emirati Arabi Uniti 16
MA - Marocco 14
PK - Pakistan 14
CH - Svizzera 13
KE - Kenya 13
DZ - Algeria 12
PY - Paraguay 12
CR - Costa Rica 10
CZ - Repubblica Ceca 10
LB - Libano 10
NP - Nepal 10
PE - Perù 10
TT - Trinidad e Tobago 10
AL - Albania 9
CY - Cipro 9
IL - Israele 9
JO - Giordania 9
KG - Kirghizistan 9
MD - Moldavia 8
PT - Portogallo 8
DK - Danimarca 7
LT - Lituania 7
MM - Myanmar 7
BG - Bulgaria 6
HN - Honduras 6
HU - Ungheria 6
NI - Nicaragua 6
TN - Tunisia 6
UY - Uruguay 6
BB - Barbados 5
BH - Bahrain 5
DO - Repubblica Dominicana 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
OM - Oman 5
BO - Bolivia 4
BY - Bielorussia 4
MN - Mongolia 4
NG - Nigeria 4
PA - Panama 4
PR - Porto Rico 4
BZ - Belize 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
KZ - Kazakistan 3
RS - Serbia 3
SN - Senegal 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AW - Aruba 2
Totale 67.520
Salva come PNG Salva come JPEG
Città #
Woodbridge 11.601
Wilmington 10.688
Houston 10.035
Singapore 1.796
Fairfield 1.552
Ashburn 1.213
San Jose 1.033
Hong Kong 782
Ann Arbor 740
Seattle 645
Chandler 574
Cambridge 513
Beijing 496
Dublin 468
Rome 437
Jacksonville 415
Council Bluffs 398
Medford 336
New York 314
Santa Clara 300
Los Angeles 291
Tokyo 257
The Dalles 217
Dearborn 176
Lawrence 161
Dallas 154
Kraków 152
Milan 150
Ho Chi Minh City 147
Buffalo 140
Lauterbourg 139
Hanoi 115
Moscow 108
Boardman 103
San Diego 97
São Paulo 97
Engelhard 93
Helsinki 92
London 91
Atlanta 89
Chicago 83
Orem 80
Secaucus 77
Menlo Park 74
Phoenix 68
Redondo Beach 66
Brooklyn 65
Jakarta 60
Denver 56
Frankfurt am Main 56
Munich 56
Toronto 56
Redwood City 51
Chennai 47
San Francisco 45
Guangzhou 40
Manchester 36
Hangzhou 35
Amsterdam 34
Warsaw 34
Montreal 33
Seoul 33
North Bergen 32
Lappeenranta 31
Bologna 30
Newark 30
Mülheim 29
Norwalk 29
Nuremberg 29
Mountain View 28
Seongnam 28
Miami 27
Johannesburg 26
Rio de Janeiro 26
Columbus 25
Verona 25
Shanghai 24
Detroit 23
Florence 23
Las Vegas 23
Washington 23
Anzio 22
Brussels 22
Curitiba 22
Haiphong 22
Memphis 22
Nanjing 22
Naples 22
Philadelphia 22
San Antonio 22
Stockholm 22
Sydney 22
Zhengzhou 22
Salt Lake City 21
Da Nang 20
Hefei 20
Suzhou 20
Bangkok 19
Charlotte 19
Mexico City 19
Totale 49.303
Salva come PNG Salva come JPEG
Nome #
A Review of Studies on the Treatment of Premature Ejaculation with Traditional Chinese Medicine 2.657
The Inferto-Sex Syndrome (ISS): sexual dysfunction in fertility care setting and assisted reproduction 1.731
Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F 1.327
Measurement of the thickness of the urethrovaginal space in women with or without vaginal orgasm 835
Beyond the G-spot: clitourethrovaginal complex anatomy in female orgasm 734
Perception of orgasmic intensity changes between clitorally and vaginally activated orgasm: a psychometric analysis using the Orgasmometer scale 607
Who has the worst attitudes toward sexual minorities? Comparison of transphobia and homophobia levels in gender dysphoric individuals, the general population and health care providers 582
The ontogenetic expression pattern of type 5 phosphodiesterase correlates with androgen receptor expression in rat corpora cavernosa 569
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 561
Hypersexuality: The controversial mismatch of the psychiatric diagnosis 544
Psychoticism, Immature Defense Mechanisms and a Fearful Attachment Style are Associated with a Higher Homophobic Attitude 529
ATRA and KL promote differentiation toward the meiotic program of male germ cells 510
Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin 507
UV and genotoxic stress induce ATR relocalization in mouse spermatocytes 501
Italian Validation of Homophobia Scale (HS) 500
The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction 488
Antitumor effects of saffron-derived carotenoids in prostate cancer cell models 487
Prevalence of chronic prostatitis in men with premature ejaculation. 486
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease. 485
Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG 479
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome 477
Effects of testosterone replacement on response to sildenafil citrate 476
Opposing effects of retinoic acid and FGF9 on Nanos2 expression and meiotic entry of mouse germ cells 468
Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. 466
SIEDY Scale 3, a New Instrument to Detect Psychological Component in Subjects with Erectile Dysfunction. 464
Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility 463
Alexithymia and vaginismus: a preliminary correlation perspective. 462
The impact of premature ejaculation on the subjective perception of orgasmic intensity: validation and standardisation of the ‘Orgasmometer’ 459
ATP-content and kinetics of acrosome reaction in human spermatozoa: influence of various culture media and incubation time 458
Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism 458
New insights from one case of female ejaculation. 456
The sexual attraction toward disabilities: a preliminary internet-based study. 456
Female orgasm(s): one, two, several. 455
Essential role of sox2 for the establishment and maintenance of the germ cell line 455
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 448
Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions 445
Epidemiology of delayed ejaculation 445
Interplay Between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis 444
An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation 443
Regulation of phosphodiesterase 5 expression and activity in human pregnant and non-pregnant myometrial cells by human chorionic gonadotropin 441
Premature ejaculation: old story, new insights 440
Ontogenetic profile and thyroid hormone regulation of type-1 and type-8 glucose transporters in rat Sertoli cells. 439
Ethical aspects of sexual medicine. Internet, vibrators, and other sex AIDS: toys or therapeutic instruments? 438
Kallmann's syndrome and normosmic isolated hypogonadotropic hypogonadism: two largely overlapping manifestations of one rare disorder 437
Subcellular localization and regulation of type-1C and type-5 phosphodiesterases 435
Exposure to mother's pregnancy and lactation in infancy is associated with sexual attraction to pregnancy and lactation in adulthood 435
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 435
Which are the male factors associated with female sexual dysfunction (FSD)? 435
Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment 434
Developmental regulation of the thyroid hormone receptor alpha 1 mRNA expression in the rat testis 433
Questionnaires for assessment of female sexual dysfunction: a review and proposal for a standardized screener. 433
The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men 433
Repression of kit expression by Plzf in germ cells 432
Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: cross-sectional and longitudinal analyses 432
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitors. 431
The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil 429
Quality of life after radical prostatectomy or external beam radiotherapy for localized prostate cancer: a controlled prospective study. 427
Premature and delayed ejaculation: two ends of a single continuum influenced by Hormonal milieu 426
The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells. 425
Thyroid hormones and male sexual function 425
An update of the International Society of Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation (PE) 425
The psychosexual profile of sexual assistants: an internet-based explorative study 425
Platelet-derived growth factor regulation of type-5 phosphodiesterase in human and rat penile smooth muscle cells. 423
null 422
Standards for Clinical Trials in Male and Female Sexual Dysfunction: III. Unique Aspects of Clinical Trials in Male Sexual Dysfunction 421
Sexual dysfunction: is acupuncture a therapeutic option for premature ejaculation? 420
Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models. 420
Hormonal correlations of premature ejaculation 419
Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart 417
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease 416
First-generation phosphodiesterase type 5 inhibitors dropout: A comprehensive review and meta-analysis 416
Gender identity rather than sexual orientation impacts on facial preferences. 414
Childhood maltreatment in subjects with male-to-female gender identity disorder. 413
Premature Ejaculation Results in Female Sexual Distress: Standardization and Validation of a New Diagnostic Tool for Sexual Distress, the FSDS-R-PE 409
Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance 409
Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models. 406
Subcellular localization and regulation of type-1C and type-5 phosphodiesterases 403
Cross-cultural and socio-demographic correlates of homophobic attitude among university students in three European countries 403
Evaluation of premature ejaculation. 402
The pathophysiology of acquired premature ejaculation 402
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer. 400
Risk Factors Associated with Primary and Secondary Reduced Libido in Male Patients with Sexual Dysfunction. 399
The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. 399
Standards for Clinical Trials in Male and Female Sexual Dysfunction: IV. Unique Aspects of Clinical Trials in Female Sexual Dysfunction 397
Pregnant Women's Preferences for Men's Faces Differ Significantly from Nonpregnant Women 396
Bisexuality among a cohort of university students: prevalence and psychological distress 392
Transdermal electromotive administration of verapamil and dexametasone for Peyronie’s disease 391
Standards for Clinical Trials in Male and Female Sexual Dysfunction: II. Patient-Reported Outcome Measures 391
Case studies. A practical approach to premature ejaculation. 389
Couplepause: A New Paradigm in Treating Sexual Dysfunction During Menopause and Andropause 389
Subclinical erectile dysfunction: proposal for a novel taxonomic category in sexual medicine 385
Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models 384
Commentary on the PAPER by Dr. A. Ostrzenski: "G-Spot Anatomy: A New Discovery". 382
SIAMS survey on sexological screening during the assisted reproductive technologies in Italy 378
Is Testosterone a Food for the Brain? 378
Pilot Echographic Study of the Differences in Clitoral Involvement following Clitoral or Vaginal Sexual Stimulation. 377
The hormonal control of ejaculation 374
Psychosocial issues of ART in aging male. 372
Attachment styles and sexual dysfunctions: a case-control study of female and male sexuality 369
A practical approach to premature ejaculation. Introduction: the asynchronous couple. 368
Totale 48.907
Salva come PNG Salva come JPEG
Categoria #
all - tutte 164.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.736
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.835 87 206 101 101 71 123 149 99 144 155 150 449
2022/20232.057 230 116 64 188 189 486 202 135 209 50 108 80
2023/20241.571 133 58 127 59 123 143 96 67 78 405 71 211
2024/20257.184 164 1.056 474 298 191 493 689 286 586 527 1.273 1.147
2025/202616.486 843 3.229 1.151 649 999 487 1.343 1.324 1.379 1.203 2.022 1.857
2026/202788 88 0 0 0 0 0 0 0 0 0 0 0
Totale 68.623